Skip to main content

Abstract

Cardiovascular diseases (CVD) are a group of disorders of the heart and blood vessels and include coronary heart disease (CHD), cerebrovascular disease, raised blood pressure (hypertension), rheumatic heart disease, angina, peripheral arterial disease, atherosclerosis, congenital heart disease, heart failure, and deep vein thrombosis (WHO 2009). Cardiovascular disease is the leading cause of death worldwide accounting for about 40 % of global mortality and 10.3 % of the global burden of disease. The incidence of CVD has risen greatly in low- and middle-income countries (Yusuf et al. 2001). Among cardiovascular disease, CHD is the most common heart disease, responsible for 40–60 % of all deaths and is invariably associated with atherosclerosis (thickening of the arteries). Atherosclerosis is a major cause of CVD that develops slowly over decades. In atherosclerosis, narrowing of the vessel’s lumen may lead to obstruction and to its clinical manifestations, such as myocardial infarction (MI) (Lefant and Savage 1995). Although women do not suffer from this problem as frequently as men, but it is numerically more significant in the case of older women. It has been reported that the risk of CHD is more in postmenopausal women (Miller 1990). Angina pectoris is one of the several expressions and one of possible manifestations of coronary heart disease. It is precipitated when the oxygen demands of the myocardium exceeds the available arterial oxygen supply. The major modifiable risk factors for CVD include high blood pressure (hypertension), high total cholesterol, obesity, physical inactivity, unhealthy diet, diabetes mellitus (DM), and homocysteine levels (Mackay and Mensah 2004). The more risk factors a person has, the greater the likelihood of developing CVD. Risk of CHD is two- to threefold higher in persons having type II diabetes as compared to general population (Fox et al. 2004). In diabetes, cardiovascular disease affects both men and women to the same extent (Uusitupa et al. 1993). It has been observed that women with diabetes, regardless of menopausal status, have a four- to sixfold higher risk of developing CVD, whereas men with diabetes have a two- to threefold increased risk of CVD compared to women and men without diabetes (Legato et al. 2006). Individuals having DM also face the risk of developing atherosclerosis due to the disturbances in the lipid metabolism (Adlerberth et al. 1998). Furthermore, high-density lipoprotein cholesterol (HDL cholesterol) that is commonly regarded as protective is decreased in diabetic patients. Diabetes mellitus acts as an independent risk factor for several forms of CVD, and it has been estimated that approximately 65 % of CVD-caused deaths are of the persons with DM (Geiss et al. 1995). Diabetes accounts for 6 % of total global mortality, with 50 % of diabetes-associated deaths being attributed to CVD (International Diabetes Federation 2008).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Adlerberth AM, Rosengren A, Wilhelmsen L (1998) Diabetes and long-term risk of mortality from coronary and other causes in middle-aged Swedish men. A general population study. Diabetes Care 21(4):539–545

    Article  CAS  Google Scholar 

  • Al-Delaimy WK, Rimm EB, Willett WC (2004) Magnesium intake and risk of coronary heart disease among men. J Am Coll Nutr 23:63–70

    Article  CAS  Google Scholar 

  • Aliabadi H (2008) A deleterious interaction between copper deficiency and sugar ingestion may be the missing link in heart disease. Med Hypotheses 70(6):1163–1166

    Article  CAS  Google Scholar 

  • Chausmer A (1998) Zinc, insulin and diabetes. J Am Coll Nutr 17:109–115

    Article  CAS  Google Scholar 

  • Feroci G, Badiello R, Fini A (2005) Interactions between different selenium compounds and zinc, cadmium and mercury. J Trace Elem Med Biol 18:227–234

    Article  CAS  Google Scholar 

  • Fox CS, Sullivan L, D’Agostino RB Sr, Wilson PW (2004) The significant effect of diabetes duration on coronary heart disease mortality: the Framingham Heart Study. Diabetes Care 27(3):704–708

    Article  Google Scholar 

  • Geiss LS, Herman WH, Smith PJ, National Diabetes Data Group (1995) Diabetes in America. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, pp 233–257

    Google Scholar 

  • Gonzalez S, Huerta JM, Alvarez-Uria J, Fernandez S, Patterson AM, Lasheras C (2004) Serum selenium is associated with plasma homocysteine concentrations in elderly humans. J Nutr 134(7):1736–1740

    CAS  Google Scholar 

  • Helmersson J, Arnlov J, Vessby B, Larsson A, Alfthan G, Basu S (2005) Serum selenium predicts levels of F2-isoprostanes and prostaglandin F2α in a 27 year follow-up study of Swedish men. Free Radic Res 39:763–770

    Article  CAS  Google Scholar 

  • Howard BV, Lee ET, Yeh JL, Go O, Fabsitz RR, Devereux RB, Welty TK (1996) Hypertension in adult American Indians. Hypertension 28:256–264

    Article  CAS  Google Scholar 

  • International Diabetes Federation (2008) Diabetes prevalence [article online]. Available from http://www.idf.org/home/index.cfm?node=264

  • Jenner A, Ren B, Rajendran R, Ning P, Huat BTK, Watt F, Halliwell B (2007) Zinc supplementation inhibits lipid per oxidation and the development of atherosclerosis in rabbits fed a high cholesterol diet. Free Radic Biol Med 42:559–566

    Article  CAS  Google Scholar 

  • Kh R, Khullar M, Kashyap M, Pandlu P, Uppal R (2000) Effect of oral magnesium supplementation on blood pressure, platelet aggregation and calcium handling in deoxycorticosterone acetate induced hypertension in rats. J Hypertens 18:919–926

    Article  CAS  Google Scholar 

  • Lefant C, Savage PJ (1995) The early natural history of atherosclerosis and hypertension in the young: National Institutes of Health Perspectives. Am J Med Sci 310(Suppl 1):S3–S7

    Google Scholar 

  • Legato MJ, Gelze RA, Goland R, Ebner SA, Rajan S, Villagra V, Kosowski M (2006) Gender-specific care of the patient with diabetes: review and recommendations. Gend Med 3:131–158

    Article  Google Scholar 

  • Linder MC, Hazegh-Azam M (1996) Copper biochemistry and molecular biology. Am J Clin Nutr 63:797S–811S

    CAS  Google Scholar 

  • Linnebank M, Lutz H, Jarre E, Vielhaber S, Noelker C, Struys E (2006) Binding of copper is a mechanism of homocysteine toxicity leading to COX deficiency and apoptosis in primary neurons, PC12 and SHSY-5Y cells. Neurobiol Dis 23(3):725–730

    Article  CAS  Google Scholar 

  • Lissa EM, Bahjri SM, Ahmed WH, Al-Ama N, Ferns GA (2006) Trace element status in Saudi patients with established atherosclerosis. J Trace Elem Med Biol 20:105–114

    Article  Google Scholar 

  • Ma B, Lawson AB, Liese AD (2006) Dairy, magnesium, and calcium intake in relation to insulin sensitivity: approaches to modeling a dose-dependent association. Am J Epidemiol 164:449–458

    Article  Google Scholar 

  • Mackay J, Mensah G (2004) Atlas of heart disease and stroke. World Health Organization, Geneva

    Google Scholar 

  • Mazur A, Maier JAM, Rock E (2007) Magnesium and the inflammatory response: potential physiopathological implications. Arch Biochem Biophys 458:48–56

    Article  CAS  Google Scholar 

  • Miller VT (1990) Dyslipoproteinemia in women. Special considerations. Endocrinol Metab Clin North Am 19(2):381–398

    CAS  Google Scholar 

  • Mostert V (2000) Selenoprotein P: properties, functions and regulation. Arch Biochem Biophys 376:433–438

    Article  CAS  Google Scholar 

  • Navarro-Alarcon M, López-Martínez MC (2000) Essentiality of selenium in the human body: relationship with different diseases. Sci Total Environ 249:347–371

    Article  CAS  Google Scholar 

  • Nayak D, Karmen C, Frishman W, Vakili B (2001) Antioxidant vitamins and enzymatic and synthetic oxygen-derived free radical scavengers in the prevention and treatment of cardiovascular disease. Heart Dis 3(1):28–45

    Article  CAS  Google Scholar 

  • Powell S (2000) The antioxidant properties of zinc. J Nutr 130:1447S–1454S

    CAS  Google Scholar 

  • Rajpathak S, Rimm E, Morris JS, Hu F (2005) Toenail selenium and cardiovascular disease in men with diabetes. J Am Coll Nutr 24:250–256

    Article  CAS  Google Scholar 

  • Ravn-Haren G, Bugel S, Krath BN, Hoac T, Stagsted J, Jorgensen K, Bresson JR, Larsen EH, Dragsted LO (2008) A short-term intervention trial with selenate, selenium-enriched yeast and selenium enriched milk: effects on oxidative defense regulation. Br J Nutr 99:883–892

    CAS  Google Scholar 

  • Rayman MP (2000) The importance of selenium to human health. Lancet 356:233–241

    Article  CAS  Google Scholar 

  • Roussel AM, Kerkeni A, Zouari N, Mahjoub S, Matheau JM, Anderson R (2003) Antioxidant effects of zinc supplementation in Tunisians with type 2 diabetes mellitus. J Am Coll Nutr 22:316–321

    Article  CAS  Google Scholar 

  • Shaper G, Kazantzis G, Schoental R (1979) Cardiovascular disease and trace metals. Proc R Soc Lond B 205:135–143

    Article  CAS  Google Scholar 

  • Shekelle RB, Shryock AM, Oblesby P (1981) Diet, serum cholesterol, and death from coronary heart disease: the Western Electric Study. N Engl J Med 304:65–70

    Article  CAS  Google Scholar 

  • Speich M, Pineau A, Ballereau F (2001) Minerals, trace elements and related biological variables in athletes and during physical activity. Clin Chim Acta 312(1–2):1–11

    Article  CAS  Google Scholar 

  • Suarez A, Pulido N, Casla A (1995) Impaired tyrosine-kinase activity of muscle insulin receptors from hypomagnesaemia rats. Diabetologia 38:1262–1270

    Article  CAS  Google Scholar 

  • Teragawa H, Kato M, Yamagat T, Matsuura H, Kajiyama G (2000) The preventive effect of magnesium on coronary spasm in patients with vasospastic angina. Chest 118:1690–1695

    Article  CAS  Google Scholar 

  • Uusitupa MIJ, Niskanen LK, Siitonen O, Voutilainen E, Pyörälä K (1993) Ten-year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in type 2 (non-insulin-dependent) diabetic and non-diabetic subjects. Diabetologia 36:1175–1184

    Article  CAS  Google Scholar 

  • Vitale J (1992) Magnesium deficiency and cardiovascular disease. Lancet 340:1224

    Article  CAS  Google Scholar 

  • Vlad M, Berdas E, Tomas R, Sava D, Frakas E, Usa G (1993) Effect of copper sulfate in experimental atherosclerosis. Biol Trace Elem Res 38:47–54

    Article  CAS  Google Scholar 

  • Waśkiewicz A, Piotrowski W, Sygnowska E, Broda G, Drygas W, Zdrojewski T, Kozakiewicz K, Tykarski A, Biela U (2008) Quality of nutrition and health knowledge in subjects with diagnosed cardiovascular diseases in the Polish population – National Multi-centre Health Survey (WOBASZ). Kardiol Pol 66:507–513

    Google Scholar 

  • Wenger NK (2003) Coronary heart disease: the female heart is vulnerable. Prog Cardiovasc Dis 46:199–229

    Article  Google Scholar 

  • Whelton PK (1994) Epidemiology of hypertension. Lancet 334:101–106

    Article  Google Scholar 

  • World Health Organization (WHO) (2009) Fact sheet about cardiovascular disease

    Google Scholar 

  • Yusuf S, Reddy S, Ôunpuu S, Anand S (2001) Global burden of cardiovascular diseases, part I: general considerations, the epidemiological transition, risk factors, and impact of urbanization. Circulation 104:2746–2753

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Rizvi, N.B., Nagra, S.A. (2014). Introduction: Minerals. In: Minerals and Lipids Profiles in Cardiovascular Disorders in South Asia. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-34249-3_1

Download citation

Publish with us

Policies and ethics